IFNAR1 and systemic lupus erythematosus: In addition, in a single-cell RNA-Seq dataset of T cells from 7 patients with SLE treated with anifrolumab (anti-IFNAR), IFN-I blockade increased a T cell stemness score (TCF7, LEF1) (48) (Supplemental Figure 6, E and F).